NCT02767388
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Clinical trial condition
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.
601 public trials
70 recruiting studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results
Completed
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
NCT04048564
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- CHU SUD Reunion GHSR Saint-Pierre, Reunion, France
- CHU Amiens-Picardie- Site SUD Amiens, France
- CHU D'Angers Angers, France
- CH Annecy Annecy, France
NCT03625388
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
- Locations
-
- King Hussein Cancer Center (KHCC) Amman, Jordan
- Jordan University Hospital (JUH) Amman, Jordan
- American University of Beirut Medical Center (AUBMC) Beirut, Lebanon
- The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia
NCT00003838
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +23 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02661035
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, B-cell Lymphoma, +59 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT06042660
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
Not specified
NCT01696461
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Emory University Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01951885
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
NCT05734053
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
- Novartis Investigative Site Aschaffenburg, Bavaria, Germany
- Novartis Investigative Site Augsburg, Bavaria, Germany
- Novartis Investigative Site Bayreuth, Bavaria, Germany
NCT03267186
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States